Novartis Investigative site

Bucaramanga

0 studies enrolling now · 8 studies all time

What they study most

Asthma, Carcinoma, Renal Cell, Chronic Plaque Psoriasis, Diffuse Large B-cell Lymphoma, Gouty Arthritis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma — Completed
• Systemic Corticosteroids Avoidance Study in Severe Asthma Patients — Stopped early
• Long Term Study of Canakinumab (ACZ885) in Patients With Gout — Completed
• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis — Completed
• Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed